Novel composition

Details for Australian Patent Application No. 2003236490 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

18 September 2003 Application Open to Public Inspection

Published as AU-B-2003236490

19 August 2004 Application Accepted

Published as AU-B-2003236490

16 December 2004 Standard Patent Sealed

1 May 2008 Extension of Term of Standard Patents

SmithKline Beecham Biologicals S.A. The earliest first regulatory approval date provided by the patentee 18 May 2007 For the goods Human Papillomavirus Cervarix Address for service in Australia: Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

25 September 2008 Extension granted

SmithKline Beecham Biologicals S.A. The earliest first regulatory approval date provided by the patentee 18 May 2007 For the goods CERVARIX Human Papillomavirus vaccine Types 16 and 18 Extension of Term of patent pursuant to Section 77 expires on 18 May 2022

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.